Abstract: Deep neural networks (DNNs) have achieved satisfactory performance in multiple fields. However, recent studies have shown that DNNs can be easily fooled by adversarial examples. To mitigate ...
WILMINGTON, Del., March 17, 2026 (GLOBE NEWSWIRE)-- Prelude Therapeutics Incorporated (Nasdaq: PRLD), a precision oncology company, today announced that a poster with preclinical data on the Company’s ...